ATE279197T1 - Methode und zusammenstellung zur prophylaxe der narbenbildung bei glaukomatösen filtrationsblasen und drainagefisteln - Google Patents

Methode und zusammenstellung zur prophylaxe der narbenbildung bei glaukomatösen filtrationsblasen und drainagefisteln

Info

Publication number
ATE279197T1
ATE279197T1 AT00911536T AT00911536T ATE279197T1 AT E279197 T1 ATE279197 T1 AT E279197T1 AT 00911536 T AT00911536 T AT 00911536T AT 00911536 T AT00911536 T AT 00911536T AT E279197 T1 ATE279197 T1 AT E279197T1
Authority
AT
Austria
Prior art keywords
glaucomatus
prophylaxis
bladder
filtration
composition
Prior art date
Application number
AT00911536T
Other languages
English (en)
Inventor
Johan Stjernschantz
Bahram Resul
Original Assignee
Synphora Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synphora Ab filed Critical Synphora Ab
Application granted granted Critical
Publication of ATE279197T1 publication Critical patent/ATE279197T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/908—Mechanical repair performed/surgical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT00911536T 1999-02-25 2000-02-23 Methode und zusammenstellung zur prophylaxe der narbenbildung bei glaukomatösen filtrationsblasen und drainagefisteln ATE279197T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9900672A SE9900672D0 (sv) 1999-02-25 1999-02-25 Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula
PCT/SE2000/000357 WO2000050040A1 (en) 1999-02-25 2000-02-23 Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula

Publications (1)

Publication Number Publication Date
ATE279197T1 true ATE279197T1 (de) 2004-10-15

Family

ID=20414625

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00911536T ATE279197T1 (de) 1999-02-25 2000-02-23 Methode und zusammenstellung zur prophylaxe der narbenbildung bei glaukomatösen filtrationsblasen und drainagefisteln

Country Status (9)

Country Link
US (1) US6495563B1 (de)
EP (1) EP1161245B1 (de)
JP (1) JP2003521467A (de)
AT (1) ATE279197T1 (de)
AU (1) AU767411B2 (de)
CA (1) CA2363131A1 (de)
DE (1) DE60014869T2 (de)
SE (1) SE9900672D0 (de)
WO (1) WO2000050040A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090162417A1 (en) * 2007-12-21 2009-06-25 Cook Incorporated Drug eluting ocular conformer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3981880A (en) * 1969-03-14 1976-09-21 The Upjohn Company Racemic prostaglandins of the 2-series and analogs thereof
US3954844A (en) 1975-01-03 1976-05-04 G. D. Searle & Co. (5Z,13E,15S)-15-Hydroxy-11-oxoprosta-5,9.13-trien-1-oic acid and esters
JPS58216155A (ja) * 1982-06-10 1983-12-15 Ono Pharmaceut Co Ltd 新規なプロスタグランジンｄ類似化合物
DE3785602T2 (de) 1986-03-13 1993-09-02 Univ Columbia Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
GB2209939B (en) 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
EP1348437A3 (de) * 1988-09-06 2003-11-19 Pharmacia Aktiebolag Prostaglandinderivative zur Behandlung von Glaukoma oder okuläre Hypertension
ATE111736T1 (de) 1988-10-01 1994-10-15 R Tech Ueno Ltd Okulare hypotensive mittel.
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
SE9401087D0 (sv) 1994-03-31 1994-03-31 Pharmacia Ab New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
SE9403158D0 (sv) * 1994-09-21 1994-09-21 Pharmacia Ab New use of prostaglandins

Also Published As

Publication number Publication date
AU3340200A (en) 2000-09-14
DE60014869D1 (de) 2004-11-18
AU767411B2 (en) 2003-11-06
WO2000050040A8 (en) 2003-02-06
WO2000050040A1 (en) 2000-08-31
CA2363131A1 (en) 2000-08-31
EP1161245B1 (de) 2004-10-13
SE9900672D0 (sv) 1999-02-25
DE60014869T2 (de) 2006-03-09
EP1161245A1 (de) 2001-12-12
JP2003521467A (ja) 2003-07-15
US6495563B1 (en) 2002-12-17

Similar Documents

Publication Publication Date Title
ATE469613T1 (de) Implantat und verfahren zur behandlung einer implantatfläche
ATE372124T1 (de) Zusammensetzung und verfahren zur perkutanen superoxygenierung
AU2002338483A1 (en) Drainage implant for draining aqueous humour from the anterior aqueous chamber of the eye into schlemm's canal
NO20031471L (no) Glykoformer av faktor VII
ATE336247T1 (de) Verwendung von selektiven ep4 rezeptor agonisten zur behandlung von krankheiten
ATE302017T1 (de) Zusammensetzung zur behandlung von durch arterielle irrigationsdefekt gewebeschäden
HUP9802678A2 (hu) Biciklusos aminszármazékok és ezeket tartalmazó PGD2 antagonista hatású készítmények
GEP20094780B (en) Prostaglandin nitrooxyderivatives
WO2003047513A3 (en) Method for treating ocular hypertension
WO2002098350A3 (en) Pyranoindazoles and their use for the treatment of glaucoma
NO20052751L (no) Oftalmisk preparat for behandling av okulaer hypertensjon.
WO2001064200A3 (en) Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
NO20025405D0 (no) Modulatorer for TNF-alfa-signalisering
ATE279197T1 (de) Methode und zusammenstellung zur prophylaxe der narbenbildung bei glaukomatösen filtrationsblasen und drainagefisteln
DE60222168D1 (de) Antagonisten der prostaglandin ep2 und/oder ep4 rezeptoren zur behandlung von menorrhagie
DK1532131T3 (da) Motilid-forbindelser
ATE409491T1 (de) Orhthalmologische zusammenstellungen zur behandlung von ocularer hypertension
WO2002102978A3 (en) Human growth hormone antagonists
WO2004019874A3 (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
DE60130030D1 (de) Verfahren zur behandlung von glaukom
MXPA04006029A (es) Derivados novedosos de benzofuranimidazolina y benzodifuranimidazolina y su uso para el tratamiento de glaucoma.
NO20035043D0 (no) Fremgangsmåte for behandling av okular hypertensjon og glaukom
PL368565A1 (en) Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma
HUP0300391A3 (en) Use of prostaglandin related compounds for preparation of composition for use in treatment of ocular hypertension and glaucoma
ZA200302911B (en) Method and composition for treatment of ocular hypertension and glaucoma.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties